Establishment of a First‑line Second‑line Treatment Model for Human Pulmonary Adenocarcinoma

Oncology Letters - Greece
doi 10.3892/ol.2016.5299
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Second Experience

American Journal of Hematology
Hematology
2018English

Impact of Second-Line Treatment on Overall Survival of Advanced Lung Adenocarcinoma Patients

2016English

Second-Line Treatment for Renal Cell Cancer

British Journal of Cancer
Cancer ResearchOncology
2012English

Second-Line Treatment of Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
2000English

Establishment and Characterization of a Human Cholangiocarcinoma Cell Line

Oncology Reports
MedicineCancer ResearchOncology
2007English

Survival Benefits of Second-Line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2020English

Prolonged Response to First-Line Erlotinib for Advanced Lung Adenocarcinoma

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2008English

Impact of First-Line Sildenafil Monotreatment for Pulmonary Arterial Hypertension

Circulation Journal
MedicineCardiovascular MedicineCardiology
2012English

Efficacy of Potassium-Competitive Acid Blocker vs Proton Pump Inhibitor as First-Line and Second-Line Treatment for Helicobacter Pylori Eradication

Open Journal of Gastroenterology and Hepatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy